Pure Global
NCT05876533

R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances

An Observational, Retrospective, Single-arm, Open US and Israel Study , for Usability Assessment and Algorithm, Development of the Cordio HearO™ Systeam
Cordio Medical·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Chronic Heart Failure
Drug/Device/Intervention
Cordio HearO
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Cordio Medical
Location
South Windsor,Athens,Ashkelon,Be'er Sheva,Petah tikva, Israel,United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 18, 2022
End date
Sep 30, 2024
Enrollment
250 participants
Primary outcome

Patient Usability success defined as: 1.Total and individual usability score of ≥3 in the usability questionnaire in ≥80% of the users.,Patient Usability success defined as: 2. Total Compliance

Summary

To determine the usability and technical aspects of Cordio HearO™

ICD-10 classifications
Heart failureHeart failure, unspecifiedCongestive heart failureHypertensive heart disease with (congestive) heart failureHypertensive heart disease without (congestive) heart failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05876533
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05876533 through Pure Global AI's free database. This phase not specified trial is sponsored by Cordio Medical and is currently Recruiting. The study focuses on Chronic Heart Failure. Target enrollment is 250 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.